HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Xavier Cubiró Selected Research
Xavier Cubiró Research Topics
Disease
1
Calcinosis Cutis
12/2022
1
Melanoma (Melanoma, Malignant)
01/2022
1
Lichen Planus (Lichen Ruber Planus)
01/2022
1
Psoriasis (Pustulosis Palmaris et Plantaris)
11/2021
1
Hereditary Hemorrhagic Telangiectasia
11/2021
1
Telangiectasis (Telangiectasia)
11/2021
1
Pityriasis Rubra Pilaris
03/2021
1
Lymphopenia (Lymphocytopenia)
11/2020
1
Hidradenitis Suppurativa
11/2020
1
Sacroiliitis
11/2020
1
Angiolymphoid Hyperplasia with Eosinophilia
01/2018
1
Paronychia
01/2018
Drug/Important Bio-Agent (IBA)
2
Adalimumab (Humira)
FDA Link
11/2021 - 11/2020
1
sodium thiosulfate
FDA Link
12/2022
1
Calcium
IBA
12/2022
1
Salts
IBA
12/2022
1
pembrolizumab
IBA
01/2022
1
Neodymium
IBA
11/2021
1
yttrium-aluminum-garnet
IBA
11/2021
1
brodalumab
IBA
03/2021
1
Ustekinumab (CNTO 1275)
FDA Link
03/2021
1
guselkumab
IBA
11/2020
1
fibrin fragment D (D-dimer)
IBA
11/2020
1
C-Reactive Protein
IBA
11/2020
1
Ferritins (Ferritin)
IBA
11/2020
1
Interleukin-6 (Interleukin 6)
IBA
11/2020
1
ErbB Receptors (EGF Receptor)
IBA
01/2018
1
Timolol (Blocadren)
FDA Link
Generic
01/2018
1
Capecitabine (Xeloda)
FDA Link
01/2018
Therapy/Procedure
1
Dye Lasers
11/2021
1
Solid-State Lasers
11/2021